Article

Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of…

International Journal of Nanomedicine · 2017 · Brault J, Vaganay G, Le Roy A, Lenormand JL, Cortes S, Stasia MJ

Key facts

Title Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells
First author Brault J, Vaganay G, Le Roy A, Lenormand JL, Cortes S, Stasia MJ
Journal International Journal of Nanomedicine
Published Mar 20, 2017
DOI 10.2147/IJN.S128611
Devices mentioned K081378, K800552, K801561, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529 and 12 more
Product codes mentioned DJR, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, LCP and 1 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature